Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Downgrades

Downgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Barclays Downgrades APA to Equal-Weight, Raises Price Target to $25

By Benzinga Newsdesk
Today, 8:51 AM
Barclays analyst Jeanine Wai downgrades APA (NASDAQ:APA) from Overweight to Equal-Weight and raises the price target from $20 to $25.

APA

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Barclays Downgrades Continental Resources to Underweight, Raises Price Target to $33

By Benzinga Newsdesk
Today, 8:51 AM
Barclays analyst Jeanine Wai downgrades Continental Resources (NYSE:CLR) from Equal-Weight to Underweight and raises the price target from $25 to $33.

CLR

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Barclays Downgrades Cimarex Energy to Equal-Weight, Announces $72 Price Target

By Benzinga Newsdesk
Today, 8:51 AM
Barclays analyst Jeanine Wai downgrades Cimarex Energy (NYSE:XEC) from Overweight to Equal-Weight and announces $72 price target.

XEC

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Citigroup Downgrades Consolidated Comms Hldgs to Sell, Raises Price Target to $8

By Benzinga Newsdesk
Today, 8:51 AM
Citigroup analyst Michael Rollins downgrades Consolidated Comms Hldgs (NASDAQ:CNSL) from Neutral to Sell and raises the price target from $7.5 to $8.

CNSL

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Baird Downgrades Progenity to Neutral, Lowers Price Target to $2

By Benzinga Newsdesk
Today, 8:51 AM
Baird analyst Catherine Schulte downgrades Progenity (NASDAQ:PROG) from Outperform to Neutral and lowers the price target from $4 to $2.

PROG

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Citigroup Downgrades Allstate to Neutral, Raises Price Target to $142

By Benzinga Newsdesk
Today, 8:51 AM
Citigroup analyst Suneet Kamath downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $135 to $142.

ALL

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades Benefitfocus to Sell, Announces $13 Price Target

By Benzinga Newsdesk
Today, 8:51 AM
Goldman Sachs analyst Christopher Merwin downgrades Benefitfocus (NASDAQ:BNFT) from Neutral to Sell and announces $13 price target.

BNFT

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades Vertex to Sell, Lowers Price Target to $18

By Benzinga Newsdesk
Today, 8:51 AM
Goldman Sachs analyst Christopher Merwin downgrades Vertex (NASDAQ:VERX) from Neutral to Sell and lowers the price target from $24 to $18.

VERX

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Goldman Sachs Downgrades Sapiens Intl Corp to Sell, Lowers Price Target to $27

By Benzinga Newsdesk
Today, 8:51 AM
Goldman Sachs analyst Christopher Merwin downgrades Sapiens Intl Corp (NASDAQ:SPNS) from Neutral to Sell and lowers the price target from $34 to $27.

SPNS

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target
  • Small Cap

Goldman Sachs Analyst Downgrades IMAX And Cinemark: What You Need To Know

By Phil Hall
Today, 8:51 AM
Goldman Sachs Vice President of Global Investment Research Michael Ng downgraded two major film exhibitors, Imax Corp (NYSE: IMAX) and Cinemark Holdings, Inc. (NYSE: CNK), in a newly published analysis.

CNK

Posts navigation

Previous 1 … 557 558 559 560 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service